The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center
Open accessAbstract
OBJECTIVE: To describe the clinical and microbiological features associated with fungal peritonitis in peritoneal dialysis (PD) patients at Hôpital Maisonneuve-Rosemont, from August 1996 to July 2006. METHODS: Cases were retrieved from the microbiology laboratory culture registry. Antifungal susceptibility was determined by the Clinical and Laboratory Standards Institute M27A3 method. RESULTS: Among 288 PD patients (total follow-up of 7258 patient-months), nine were found with fungal peritonitis. Candida spp were identified in all of them, with a majority of non-albicans Candida species. Resistance to fluconazole, itraconazole, or voriconazole was as frequent as potential resistance to amphotericin B. No isolate was resistant to caspofungin and one was resistant to micafungin. Prior bacterial peritonitis was frequent (67%). All patients had their PD catheter removed and all of them survived. CONCLUSIONS: In our institution, fungal peritonitis in PD patients is rare. All cases were caused by Candida species. Variable susceptibility patterns were observed, which may influence the initial empirical antifungal therapy and underscore the importance of individual speciation and susceptibility testing of invasive Candida isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high morbidity and mortality of Candida peritonitis in developed countries has been associated with the age of patients, the use of antibiotics and corticosteroid treatment [48,49,50,51].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomoto, Y., Kawaguchi, Y., Kubo, H., Hirano, H., Sakai, S., & Kurokawa, K. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90501-6 · Cited by 253 · cited 1×
“Previous peritonitis, either bacterial of fungal, may predispose to sclerosing peritonitis.(16,17) In conclusion, fungal peritonitis is a rare complication of PD that is associated with significant morbidity and mortality.”
BackgroundEncapsulating Peritoneal Sclerosis in the New Millennium: A National Cohort Study
Brown, M. C., Simpson, K., Kerssens, J. J., & Mactier, R. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01260209 · Cited by 197
Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes
Goldie, S. J., Kiernan-Troidle, L., Torres, C., Gorban-Brennan, N., Dunne, D., Kliger, A. S., & Finkelstein, F. O. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90135-3 · Cited by 189 · cited 2×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
BackgroundResultWang, A. Y. M., Yu, A. W. Y., Li, P. K. T., Lam, P. K. W., Leung, C. B., Lai, K. N., & Lui, S. F. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19833 · Cited by 186 · cited 1×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
BackgroundPredictors and outcomes of fungal peritonitis in peritoneal dialysis patients
Miles, R., Hawley, C. M., McDonald, S. P., Brown, F. G., Rosman, J. B., Wiggins, K. J., Bannister, K. M., & Johnson, D. W. (2009) · Kidney International · doi:10.1038/ki.2009.202 · Cited by 162 · cited 5×
“Although larger series of FP in PD have already been published (Miles et al., 2009, 162 cases”
BackgroundResultInfluentialUpdate on Fungal Peritonitis and its Treatment
Matuszkiewicz‐Rowińska, J. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902902s31 · Cited by 161 · cited 3×
“It represents only 3% to 6% of all episodes of peritonitis, but is associated with much greater morbidity and mortality than bacterial peritonitis.(1) Initial empirical antifungal therapy has to take into account the frequency of different species of fungi based on the local epidemiology, and their susceptibilities to…”
BackgroundResultKartsonis, N. A., Killar, J., Mixson, L. A., Hoe, C., Sable, C. A., Bartizal, K. F., & Motyl, M. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3616-3623.2005 · Cited by 138 · cited 1×
“The clinical significance of such observations remains to be determined.(6,14) It however underscores the importance of individual speciation and susceptibility testing of invasive Candida isolates.”
BackgroundFungal Peritonitis in Peritoneal Dialysis Patients
Prasad, N., & Gupta, A. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500302 · Cited by 113 · cited 5×
“All patients survived in our study, in contrast to a reported lethality of FP of between 5% and 50%.(2) The reason for this is probably multifactorial, including the relatively small number of cases in this study, the absence of fungus other than Candida in our series, and the fact that all patients had their catheter…”
BackgroundResultInfluentialFungal Peritonitis in Patients on Peritoneal Dialysis
Michel, C., Courdavault, L., Khayat, R., Viron, B. M., Roux, P., & Mignon, F. (1994) · American Journal of Nephrology · doi:10.1159/000168699 · Cited by 107
Prasad, K. N., Prasad, N., Gupta, A. K., Sharma, R. K., Verma, A. K., & Ayyagari, A. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00119-1 · Cited by 103 · cited 1×
“Wang et al., 2000, 70 cases;8 Goldie et al., 1996, 55 cases;9 Nagappan et al., 1992, 38 cases;10 Prasad et al., 2004, 28 cases;11 Michel et al., 1994, 20 cases12), antifungal susceptibility testing of isolates has been reported in only two series.”
Background
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
Li, P. K.-T., Szeto, C. C., Piraino, B., de Arteaga, J., Fan, S., Figueiredo, A. E., Fish, D. N., Goffin, E., Kim, Y.-L., Salzer, W., et al. (2016) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2016.00078 · Cited by 907
“Although fluconazole is commonly used, the prevalence of azole resistance is increasing (403).”
BackgroundPeritoneal dialysis-related peritonitis: challenges and solutions
Salzer, W. L. (2018) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s123618 · Cited by 158
“may become resistant.(65) In the event of fluconazole-resistant organisms, therapy with amphotericin B 0.”
Recent trends in molecular diagnostics of yeast infections: from PCR to NGS
Arastehfar, A. A., Boekhout, T., Butler, G., Cesare, G. B. D., Dolk, E., Gabaldón, T., Hafez, A. I., Hube, B., Hagen, F., Hovhannisyan, H., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 152
Inflammation in Peritoneal Dialysis
Lai, K. N., & Leung, J. C. K. (2010) · Nephron Clinical Practice · doi:10.1159/000314544 · Cited by 79
“Fungal peritonitis accounts for about 4–6% of episodes of the total incidence of the peritonitis, and is with high mortality [14].”
Metadata
- Authors
- Levallois, J., Nadeau-Fredette, A.-C., Labbé, A.-C., Laverdière, M., Ouimet, D., & Vallée, M.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Corresponding author
- Vallée, Michel
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 16
- Issue
- 1
- Pages
- e41-e43
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2002605200
- Cited by
- 47
- References
- 16
- Citations by year
- 2026: 4 · 2025: 2 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 1 · 2013: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 599 d)
- Locations
- International Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- fungal peritonitis, peritoneal dialysis, Candida, non-albicans Candida, antifungal susceptibility, fluconazole resistance, itraconazole resistance, voriconazole resistance, amphotericin B resistance, caspofungin, micafungin, peritoneal catheter removal, invasive candidiasis
- MeSH terms
- Caspofungin, Micafungin, Adult, Aged, Amphotericin B, Antifungal Agents, Candida, Female, Follow-Up Studies, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Mycoses, North America, Peritoneal Dialysis, Peritonitis, Pyrimidines, Triazoles, Fluconazole, Itraconazole, Drug Resistance, Fungal, Echinocandins, Lipopeptides, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.